Literature DB >> 32109644

Minimum 2-Year Efficacy of Percutaneous Endoscopic Lumbar Discectomy versus Microendoscopic Discectomy: A Meta-Analysis.

Jietao Xu1, Yawei Li1, Bing Wang2, Guohua Lv1, Lei Li1, Yuliang Dai1, Bin Jiang1, Zhenzhong Zheng1.   

Abstract

BACKGROUND: Minimally invasive surgery in the treatment of lumbar disc herniation has gained popularity in recent years, as 2 dominant techniques, percutaneous endoscopic lumbar discectomy (PELD) and microendoscopic discectomy (MED) obtained comparable short-term clinical outcomes. However, midterm and long-term efficacy and reoperative rate are still debated.
METHODS: Electronic databases Web of Science, PubMed, Scopus, Cochrane Library, EMBASE, Ovid, and EBSCO were searched. STATA 14.0 was used for statistical analysis. Odds ratio (OR) and 95% confidence interval (CI) were pooled to quantify the strength of the statistical differences.
RESULTS: Nine studies (468 patients in the PELD group and 516 patients in the MED group) with high methodologic quality met the selection criteria. No differences were found in leg pain visual analog scale score before surgery or at any follow-up time after surgery. PELD obtained better outcomes in low back pain visual analog scale score, Oswestry Disability Index score, and excellent and good ratio after 24 months postoperatively (OR = -0.856, 95% CI -1.488 to -0.224, P = 0.008; OR = -0.425, 95% CI -0.724 to -0.127, P = 0.005; OR = 3.034; 95% CI 1.254 to 7.343; P = 0.014) compared with MED. No difference was found within 24 months postoperatively. No significant differences were found in complication, recurrence, and reoperation rates within and after 2 years postoperatively.
CONCLUSIONS: Both PELD and MED can offer relatively effective and safe treatment for low back pain and radiculopathy associated with a herniated disc. PELD could obtain better midterm and long-term clinical outcomes compared with MED.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lumbar disc herniation; Meta-analysis; Microendoscopic discectomy; Percutaneous endoscopic lumbar discectomy

Year:  2020        PMID: 32109644     DOI: 10.1016/j.wneu.2020.02.096

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Rationale and Advantages of Endoscopic Spine Surgery.

Authors:  Jae-Won Jang; Dong-Geun Lee; Choon-Keun Park
Journal:  Int J Spine Surg       Date:  2021-12

2.  Comparative Study between Full-Endoscopic Discectomy and Microendoscopic Discectomy for the Treatment of Lumbar Disc Herniation.

Authors:  Muneyoshi Fujita; Tomoaki Kitagawa; Masahiro Hirahata; Takahiro Inui; Hirotaka Kawano; Hiroki Iwai; Hirohiko Inanami; Hisashi Koga
Journal:  Medicina (Kaunas)       Date:  2020-12-18       Impact factor: 2.430

3.  Comparative study of the efficacy and safety of minimally invasive interlaminar full-endoscopic discectomy versus conventional microscopic discectomy in single-level lumbar herniated intervertebral disc (ENDO-F Trial): a multicenter, prospective, randomized controlled trial protocol.

Authors:  Jin-Sung Kim; Jun Ho Lee; Junseok Bae; Dong Chan Lee; Sang-Ha Shin; Han Joong Keum; Young Soo Choi; Sang Soo Eun; Seung Ho Shin; Hyun Jin Hong; Ji Yeon Kim; Tae Hyun Kim; Woojung Lim; Junghoon Kim; Sang-Min Park; Hyun-Jin Park; Hong-Jae Lee
Journal:  J Orthop Surg Res       Date:  2022-03-28       Impact factor: 2.359

4.  A Case of Postoperative Recurrent Lumbar Disc Herniation Conservatively Treated with Novel Intradiscal Condoliase Injection.

Authors:  Toru Funayama; Yusuke Setojima; Yosuke Shibao; Hiroshi Noguchi; Kousei Miura; Fumihiko Eto; Kosuke Sato; Mamoru Kono; Tomoyuki Asada; Hiroshi Takahashi; Masaki Tatsumura; Masao Koda; Masashi Yamazaki
Journal:  Case Rep Orthop       Date:  2022-02-15

5.  Comparison of unilateral biportal endoscopic discectomy versus percutaneous endoscopic lumbar discectomy for the treatment of lumbar disc herniation: A systematic review and meta-analysis.

Authors:  Xu Ma; Wenyi Li; Shangju Gao; Can Cao; Chuntao Li; Liang He; Meng Li
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.